Ipsen S.A. publishes its 2022 Universal registration document
Regulated Information
Ipsen S.A. publishes its 2022 Universal registration document
- 06 April 2023 - 1 mins read
Regulated Information
Related Press Releases
20 June 2023
IPSEN – Buy-back programme – Art 5 of MAR –...
16 June 2023
Ipsen delivered sales growth and margin expansion in 2020 –...
16 June 2023
Ipsen delivers strong sales growth for the first nine months...
14 June 2023
Correction: Ipsen announces U.S. FDA submission acceptance of its supplemental...
14 June 2023
Ipsen announces U.S. FDA submission acceptance of its supplemental New...
13 June 2023
U.S. FDA approves Bylvay® for patients living with cholestatic pruritus...
13 June 2023
IPSEN – Buy-back programme – Art 5 of MAR –...
12 June 2023
Ipsen to present new data on clinical outcomes and patient...
12 June 2023
Ipsen to present new data on clinical outcomes and patient...
12 June 2023
Ipsen to present new data on clinical outcomes and patient...